Company Filing History:
Years Active: 2008
Title: Francoise Cormont: Innovator of Recombinant Anti-Interleukin-9 Antibodies
Introduction
Francoise Cormont, an accomplished inventor based in Rixensart, Belgium, has made significant contributions to the field of biotechnology with her innovative work on antibodies. With one patent to her name, Cormont's research focuses on developing medical solutions for asthma and related disorders through advanced immunological approaches.
Latest Patents
Francoise Cormont holds a patent for "Recombinant anti-interleukin-9 antibodies." This patent details the application of neutralizing chimeric and humanized anti-human IL-9 antibodies. The invention reveals the potential of using these antibodies to identify neutralizing epitopes on human IL-9. Furthermore, it outlines their application as medicaments to prevent and treat asthma, bronchial hyperresponsiveness, atopic allergy, and other related disorders. The patent specifically highlights recombinant antibodies derived from three murine anti-human IL-9 antibodies, known as MH9A3, MH9D1, and MH9L1.
Career Highlights
Throughout her career, Francoise Cormont has been associated with notable companies such as MedImmune Limited and the Ludwig Institute for Cancer Research Limited. Her work in these organizations has played an essential role in advancing her research in the field of immunology and therapeutic antibodies.
Collaborations
During her career, Cormont has collaborated with distinguished colleagues, including Jennifer Lynne Reed and William Dall'Acqua. Their joint efforts in research have contributed to numerous advancements in the understanding and treatment of immune-mediated conditions.
Conclusion
Francoise Cormont's innovative contributions to the field of biotechnology underscore her commitment to advancing medical science. With her patented work on recombinant anti-interleukin-9 antibodies, she paves the way for potential breakthroughs in treating asthma and related disorders, marking her presence as a significant inventor in her field.